B. Douglas Smith

14.5k citations
198 papers · 8.0k · 2 hit papers · h-index 47

Impact in

  • Hematology top 0.05%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
  • Genetics top 0.5%
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 104
    • Chronic Myeloid Leukemia Treatments 47
    • Hematopoietic Stem Cell Transplantation 21
    • Retinoids in leukemia and cellular processes 16

B. Douglas Smith

189 papers receiving 7.9k citations

B. Douglas Smith's Hit Papers

Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome 2018 · 356 citations
3560+7+15Years since publication200400600

Peers

B. Douglas Smith
Comparison fields: 5 of 121
  • Hematology 4.8k
  • Genetics 1.5k
  • Oncology 1.9k
  • Molecular Biology 3.4k
  • Immunology 996
Replace David A. Rizzieri with:
David A. Rizzieri United States
Christian Récher France
Paresh Vyas United Kingdom
Steven D. Gore United States
Daniel A. Pollyea United States
William Blum United States
Josef Vormoor Germany
Mark J. Levis United States
Robert Schlossman United States
Eric J. Feldman United States
B. Douglas Smith relative to David A. Rizzieri United States David A. Rizzieri's profile →
Citations per field
00.5×1.5×
David A. Rizzieri · 1×
Citations per year

Countries citing papers authored by B. Douglas Smith

Since Specialization
Citations

This map shows the geographic impact of B. Douglas Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Douglas Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Douglas Smith more than expected).

Fields of papers citing papers by B. Douglas Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Douglas Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Douglas Smith. The network helps show where B. Douglas Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside B. Douglas Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B. Douglas Smith Line = papers co-authored together B. Douglas Smith links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Characterization of clonogenic multiple myeloma cells
Hit paper breakdown →
2003604
2 2004482
3 2008409
4 2002378
5
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
Hit paper breakdown →
2018356
6 2010273
7 2014194
8 2011190
9 2004181
10 2012176
11 2006164
12 2001161
13 2003148
14 2004139
15
E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia.
2000128
16 2012125
17 2011112
18 2005109
19 200597
20 200797

About B. Douglas Smith

B. Douglas Smith is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Public Health, Environmental and Occupational Health, having authored 198 papers that have together received 8.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (104 papers), Chronic Myeloid Leukemia Treatments (47 papers), Acute Lymphoblastic Leukemia research (35 papers), Chronic Lymphocytic Leukemia Research (34 papers), Hematopoietic Stem Cell Transplantation (21 papers), Retinoids in leukemia and cellular processes (16 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers) and Eosinophilic Disorders and Syndromes (12 papers). The work is most often cited by research in Hematology (4.8k citations), Genetics (1.5k citations), Oncology (1.9k citations), Molecular Biology (3.4k citations) and Immunology (996 citations). B. Douglas Smith has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Mark J. Levis, Richard J. Jones, Donald Small, William Matsui, Judith E. Karp, Carol Ann Huff, James Barber, Qiuju Wang, Kathleen M. Murphy and Kam-Fai Tse. Their work appears in journals such as Blood, Leukemia Research, Journal of Clinical Oncology, Clinical Cancer Research and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact